Market Flash: iSHARES MSCI Indonesia Investable Market Index Fund (EIDO:US) PRICE: 28.530 USD Down -0.360 (-1.246%) >>> BI: Rupiah Melemah Akibat Kondisi Eropa >>> Pertemuan FED pertimbangkan langkah baru dorong ekonomi >>> KIJA akan Terbitkan MEN Valas USD150 Juta >>> PT Indika Energy Perusahaan Teladan Dunia 2011 >>> Govt Promises Revision of Cost Recovery Regulation >>> BPMigas Demands PGN to Pay US$6 per MMBTU >>> Jababeka to Raise US$150 Million from Debt Markets >>> SCG Chemicals buys Chandra Asri >>> Solusi Tunas eyes Rp380 bio IPO >>> SMR Utama scouts Rp300 bio IPO >>> Alam Sutera picks two bond arrangers >>> ASII Tetap Rajai Penjualan Mobil Agustus 2011 >>> Perusahaan Thailand kuasai Saham TPIA senilai Rp 3,76 Triliun >>> Agis Main ke Tambang, Sahamnya Masuk Dalam Pengawasan >>> ACES Mendekati The Northern Agar Mau Kurangi Kepemilikan >>> IHSG masih harus berjuang terus bertahan diatas MA200 >>> Melirik Peluang Akumulasi di Saham Perbankan >>> Analisa Saham BUMI: Kuat Bertahan & Berpeluang Kembali Uptrend >>> Analisa Saham JSMR: Bertahan Di Support, What Next? >>> INDF Tertahan Di Area Support Kuat, Berpeluang Rebound >>> ASII Break Minor Support, Sell on Strength >>> ADRO Membentuk Descending Wedges, Berpeluang Rebound Terbatas >>> Wall Street ends flat as early gains evaporate >>> Fed begins policy meeting, tiptoes toward easing >>> Fed meeting to help decide on long-term Treasuries >>> Greece Makes 'Good Progress' in Reform Talks: EC >>> China worried Europe debt crisis will hit trade >>> China could roll out 4.65tr yuan stimulus package >>> IMF sees Mideast stagnation >>> NYMEX-Crude ends higher at Oct contract expiry >>> Asian Crude Palm Oil Up On Technical Buying, Soyoil >>> Foreign net Sell - 61.785.746

Senin, 07 Maret 2011

BDMN:Funding remains a concern - Mandiri Sekuritas

The implementation of PSAK 50/55 has affected BDMN’s performance in FY10, particularly the net interest income. As there would be no more changes in accounting treatment this year, we expect better growth in net interest income this year, yet net profit would be slightly downgraded due to new calculation of impairment losses. We remain concerned with the bank’s funding cost due to possible liquidity drain in the banking sector post the implementation of new RR in Mar11. We thus maintain our neutral recommendation on the counter.

Better growth in net interest income this year.... We project better growth in net interest income (NII) of 8.4% yoy this year (vs 4.7% yoy in FY10) due to: (1) no more changes in accounting treatment. The PSAK 50/55 has been fully implemented in FY10, which resulted in lower growth in NII as the bank has to take into account the acquisition cost (booked by ADMF) to the bank’s NII. (2) 21% yoy loan growth this year. These loans will particularly be derived from mass market segment (including ADMF). Mass market contributed 57.9% of total loans at end Dec10, a significant increase from 53.9% at end 2009.

Concerns over funding remain. We estimated that BDMN had around Rp14tn of excess liquidity at end Dec10, which was mainly placed with BI (both FASBI and SBI). We noticed the bank’s efforts to build up its liquidity position during the year, as reflected in the significant decline in the government bond holding from Rp11.0tn at end 2009 to Rp6.1tn at end 2010. Furthermore, around Rp2.8tn of the government bond it held was placed under repurchase (repo) agreement. Additionally, the bank has also aggressively expanded its funding (+18.1% yoy in FY10) to finance its 30.6 % yoy loan expansion during the year. Assuming Rp16.8 tn of additional loans this year (+21.0% yoy), BDMN has to grow its deposits by at least 20% yoy to maintain its current liquidity position, which might be difficult to achieve given the liquidity tightening measures adopted by BI (please note that placement in SBI fell by 34.3% yoy in 2010 to Rp139tn). Such measures might pose some threat to BDMN which relies heavily on TD (TD accounted for 39.3% of total loans at end 2010).

Maintain neutral. Despite positive adjustment in NII, we slightly downgraded our net profit forecast due to impairment loss treatment. Despite that, we maintain our TP at Rp6,300/share as we remain concerned with the macro economic outlook which might affect the bank’s performance this year. At current price, the stock is trading at 2011F P/BV of 2.6x and PER of 15.6x. We maintain our neutral recommendation on the counter.

Tidak ada komentar:

Posting Komentar